-+ 0.00%
-+ 0.00%
-+ 0.00%

Canadian Business Debt Stress Might Change The Case For Investing In Equifax (EFX)

Simply Wall St·09/14/2026 16:18:04
Listen to the news
  • Equifax Canada reported that average commercial debt per business rose 7.3% year over year, while 60+ day delinquencies on financial credit products reached their highest level since 2019. This highlights mounting payment stress among Canadian firms.
  • The new Equifax dataset suggests that lenders and other financial providers relying on its credit files face a more stressed Canadian business customer base. This increases the relevance of Equifax’s risk analytics and monitoring tools for portfolio management.
  • We will examine how Equifax's investment narrative intersects with rising Canadian commercial delinquencies and what that may imply for long term risk.
Spot check your exposure to stressed borrowers by scanning our hand picked 11 resilient stocks with low risk scores, which may offer cleaner balance sheets than heavily indebted commercial lenders.

Equifax Investment Narrative Recap

Owning Equifax means believing its data, analytics and verification engines stay useful even when credit stress rises. The most important near term swing factor is how demand for credit files, risk scores and portfolio tools holds up as lenders reassess exposure to stretched borrowers. The fresh Canadian delinquency data points to heavier use of monitoring and analytics, rather than a clear hit to the broader franchise.

The largest current threat still sits in costs and competition, not this one dataset. Litigation, regulatory scrutiny and rival scoring models can pressure margins and pricing power. If legal expenses stay elevated while state level government budgets remain tight, that combination matters more to near term profitability than higher Canadian 60+ day delinquencies alone.

With no fresh company announcements tied directly to this Canadian release, the most relevant context is Equifax’s push into multi data products such as EFX.AI, Single Data Fabric and broader portfolio analytics. Those offerings directly speak to lenders trying to understand where risk is building and which borrowers are sliding into arrears.

For you as a shareholder, the question is whether Equifax can keep turning these tools into stickier relationships and incremental revenue without letting compliance, litigation and technology expenses erode the benefits. Execution on that product roadmap, and the ability to show that richer datasets improve risk detection for clients during periods of commercial strain, remains a central catalyst to watch.

Equifax's analyst narrative points to revenues of US$8.3b and earnings of US$1.3b by 2029, based on an assumed 8.8% yearly revenue growth rate and an earnings increase of about US$608.6m from current earnings of US$691.4m, as projected by analysts.

Uncover why Equifax's fair value indicates a 27% potential upside to its current price that may not remain available for long.

NYSE:EFX 1-Year Stock Price Chart
NYSE:EFX 1-Year Stock Price Chart

Exploring Other Perspectives

Three fair value views from the Simply Wall St Community span roughly US$215 to US$441 per share, which shows how far apart retail investors can be on Equifax. These opinions do not yet factor in rising Canadian commercial delinquencies or ongoing litigation and regulatory costs, so you may want to compare several contrasting angles before relying on any single estimate.

Explore 2 other Equifax fair value estimates, including one that suggests it could be worth just $214.95!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider your own analysis and judgment.

Looking For More Investment Ideas Beyond Equifax?

If Equifax has sharpened your thinking about credit risk and balance sheet strength, it can be useful to compare it with other businesses that meet clear financial criteria. The Simply Wall St Screener helps you filter for different types of opportunities so you are not relying on a single story or sector.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.